ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,01%
Bitcoin
67.706,58
0,32%
Brent Oil
81,295
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cytokinetics Inc (CYTK)

  7. Cytokinetics Inc (CYTK) Notícias

CYTK

Cytokinetics (CYTK)

Cytokinetics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CYTK
DataHoraFonteTítuloCódigoCompanhia
29/05/202417:00GlobeNewswire Inc.Cytokinetics to Participate in June Investor ConferencesNASDAQ:CYTKCytokinetics Inc
28/05/202417:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTKCytokinetics Inc
28/05/202417:00GlobeNewswire Inc.Cytokinetics Announces Closing of Public Offering of Common StockNASDAQ:CYTKCytokinetics Inc
24/05/202417:56Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CYTKCytokinetics Inc
23/05/202408:40IH Market NewsOpenAI and News Corp Seal Partnership, DuPont de Nemours Announces Division, and More NewsNASDAQ:CYTKCytokinetics Inc
23/05/202400:30GlobeNewswire Inc.Cytokinetics Announces Pricing of Public Offering of Common StockNASDAQ:CYTKCytokinetics Inc
22/05/202417:10GlobeNewswire Inc.Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D PipelineNASDAQ:CYTKCytokinetics Inc
22/05/202417:02GlobeNewswire Inc.Cytokinetics Announces Proposed Public Offering of Common StockNASDAQ:CYTKCytokinetics Inc
22/05/202417:00GlobeNewswire Inc.Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D PipelineNASDAQ:CYTKCytokinetics Inc
17/05/202408:30GlobeNewswire Inc.Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle BiologyNASDAQ:CYTKCytokinetics Inc
16/05/202419:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
15/05/202408:30GlobeNewswire Inc.Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024NASDAQ:CYTKCytokinetics Inc
13/05/202410:33GlobeNewswire Inc.Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of MedicineNASDAQ:CYTKCytokinetics Inc
13/05/202410:33GlobeNewswire Inc.Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 CongressNASDAQ:CYTKCytokinetics Inc
10/05/202417:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYTKCytokinetics Inc
08/05/202417:00GlobeNewswire Inc.Cytokinetics Reports First Quarter 2024 Financial ResultsNASDAQ:CYTKCytokinetics Inc
08/05/202408:30GlobeNewswire Inc.Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic CardiomyopathyNASDAQ:CYTKCytokinetics Inc
08/05/202408:30GlobeNewswire Inc.Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586NASDAQ:CYTKCytokinetics Inc
07/05/202417:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
07/05/202417:00GlobeNewswire Inc.Cytokinetics to Hold Annual Meeting of StockholdersNASDAQ:CYTKCytokinetics Inc
02/05/202417:00GlobeNewswire Inc.Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CYTKCytokinetics Inc
29/04/202417:00GlobeNewswire Inc.Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 CongressNASDAQ:CYTKCytokinetics Inc
24/04/202417:00GlobeNewswire Inc.Cytokinetics to Announce First Quarter Results on May 8, 2024NASDAQ:CYTKCytokinetics Inc
10/04/202408:30GlobeNewswire Inc.Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 CongressNASDAQ:CYTKCytokinetics Inc
05/04/202408:30GlobeNewswire Inc.Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific SessionNASDAQ:CYTKCytokinetics Inc
01/04/202417:00GlobeNewswire Inc.Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:CYTKCytokinetics Inc
25/03/202409:15GlobeNewswire Inc.Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific SessionNASDAQ:CYTKCytokinetics Inc
04/03/202418:00GlobeNewswire Inc.Cytokinetics to Participate in March Investor ConferencesNASDAQ:CYTKCytokinetics Inc
01/03/202420:47PR Newswire (US)Super Micro Computer and Deckers Outdoor Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600NASDAQ:CYTKCytokinetics Inc
29/02/202409:30GlobeNewswire Inc.Cytokinetics Joins Global Initiative to Recognize International Rare Disease DayNASDAQ:CYTKCytokinetics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CYTK

Seu Histórico Recente

BIT
P1P6P9
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados